Costs and Health Consequences of Chlamydia Management Strategies Among Pregnant Women in Sub-Saharan Africa
Overview
Affiliations
Objectives: Chlamydia is the most common bacterial sexually transmitted infection worldwide and a major cause of morbidity-particularly among women and neonates. We compared costs and health consequences of using point-of-care (POC) tests with current syndromic management among antenatal care attendees in sub-Saharan Africa. We also compared erythromycin with azithromycin treatment and universal with age-based chlamydia management.
Methods: A decision analytical model was developed to compare diagnostic and treatment strategies, using Botswana as a case. Model input was based upon (1) a study of pregnant women in Botswana, (2) literature reviews and (3) expert opinion. We expressed the study outcome in terms of costs (US$), cases cured, magnitude of overtreatment and successful partner treatment.
Results: Azithromycin was less costly and more effective than erythromycin. Compared with syndromic management, testing all attendees on their first visit with a 75% sensitive POC test increased the number of cases cured from 1500 to 3500 in a population of 100,000 women, at a cost of US$38 per additional case cured. This cost was lower in high-prevalence populations or if testing was restricted to teenagers. The specific POC tests provided the advantage of substantial reductions in overtreatment with antibiotics and improved partner management.
Conclusions: Using POC tests to diagnose chlamydia during antenatal care in sub-Saharan Africa entails greater health benefits than syndromic management does-and at acceptable costs-especially when restricted to younger women. Changes in diagnostic strategy and treatment regimens may improve people's health and even reduce healthcare budgets.
Marcus R, C P, Gill K, Smith P, Rouhani S, Mendelsohn A BMC Health Serv Res. 2023; 23(1):1078.
PMID: 37817160 PMC: 10566254. DOI: 10.1186/s12913-023-10068-8.
Vasudeva M, Nakka R, Stock S, Ghebremichael M Trop Med Infect Dis. 2022; 7(8).
PMID: 35893654 PMC: 9332350. DOI: 10.3390/tropicalmed7080147.
Batura N, Saweri O, Vallely A, Pomat W, Homer C, Guy R BMJ Open. 2021; 11(8):e046308.
PMID: 34385236 PMC: 8362726. DOI: 10.1136/bmjopen-2020-046308.
Saweri O, Batura N, Adawiyah R, Causer L, Pomat W, Vallely A PLoS One. 2021; 16(6):e0253135.
PMID: 34138932 PMC: 8211269. DOI: 10.1371/journal.pone.0253135.
Garrett N, Mitchev N, Osman F, Naidoo J, Dorward J, Singh R BMJ Open. 2019; 9(2):e026888.
PMID: 30782948 PMC: 6367982. DOI: 10.1136/bmjopen-2018-026888.